open access
메뉴
open access
메뉴
ISSN : 0376-4672
This paper reviewed prolotherapy as an approach to treating temporomandibular joint disorders (TMD), focusing on temporomandibular joint subluxation and hypermobility. Prolotherapy, commonly used in orthopedics, involves injecting substances like dextrose or lidocaine to promote healing in musculoskeletal conditions. Clinical studies in which this prolo therapy was used for TMD were reviewed. Total 13 papers involving 372 patients (Male 90, Female 282) were examined, considering factors such as dextrose concentration (10%~50%), injection frequency (one to four times), injection period (one to four weeks) and injection sites. The assessment primarily focused on pain reduction and changes in maximum mouth opening after prolotherapy. In all papers, a consistent trend of pain reduction after prolotherapy was observed. Regarding maximum mouth opening, there were 6 cases of decreased range and 7 cases of increased range. With prolotherapy's rec ognition as a new medical technology for TMD, it emerges as a potential alternative treatment, highlighting its significance in the field.
1. Comert Kilic S, Kilic N, Gungormus M. Botulinum Toxin Versus Dextrose Prolotherapy: Which is More Effective for Temporomandibular Joint Subluxation? A Randomized Clinical Trial, J Oral Maxillofac Surg 2023;81:389-395.
2. Bhargava D, Sivakumar B, Bhargava PG. A Comparative Preliminary Randomized Clinical Study to Evaluate Heavy Bupivacaine Dextrose Prolotherapy (HDP) and Autologous Blood Injection (ABI) for Symptomatic Temporomandibular Joint Hypermobility Disorder, J Maxillofac Oral Surg 2023;22:110-118.
3. Xu J, Ren H, Zhao S et al. Comparative effectiveness of hyaluronic acid, platelet-rich plasma, and platelet-rich fibrin in treating temporomandibular disorders: a systematic review and network meta-analysis, Head Face Med 2023;19:39.
4. Fouda AA. Change of site of intra-articular injection of hypertonic dextrose resulted in different effects of treatment, Br J Oral Maxillofac Surg 2018;56:715-718.
5. Memis S. Evaluation of the effects of prolotherapy on condyles in temporomandibular joint hypermobility using fractal dimension analysis, J Korean Assoc Oral Maxillofac Surg 2022;48:33-40.
6. Pandey SK, Baidya M, Srivastava A, Garg H. Comparison of autologous blood prolotherapy and 25% dextrose prolotherapy for the treatment of chronic recurrent temporomandibular joint dislocation on the basis of clinical parameters: A retrospective study, Natl J Maxillofac Surg 2022;13:398-404.
7. Sit RW, Reeves KD, Zhong CC et al. Efficacy of hypertonic dextrose injection (prolotherapy) in temporomandibular joint dysfunction: a systematic review and meta-analysis, Sci Rep 2021;11:14638.
8. Hackett GS. Prolotherapy in whiplash and low back pain, Postgrad Med 1960;27:214-219.
9. Hackett GS, Huang TC. Prolotherapy for sciatica from weak pelvic ligaments and bone dystrophy, Clin Med (Northfield)1961;8:2301-2316.
10. Hackett GS, Huang TC, Raftery A, Dodd TJ. Back pain following trauma and disease--prolotherapy, Mil Med 1961;126:517-525.
11. Hackett GS, Huang TC, Raftery A. Prolotherapy for headache. Pain in the head and neck, and neuritis, Headache 1962;2:20-28.
12. Taskesen F, Cezairli B. Efficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobility, Cranio 2023;41:423-431.
13. Refai H. Long-term therapeutic effects of dextrose prolotherapy in patients with hypermobility of the temporomandibular joint: a single-arm study with 1-4 years' follow up, Br J Oral Maxillofac Surg 2017;55:465-470.
14. Ungor C, Atasoy KT, Taskesen F et al. Short-term results of prolotherapy in the management of temporomandibular joint dislocation, J Craniofac Surg 2013;24:411-415.
15. Majumdar SK, Krishna S, Chatterjee A et al. Single Injection Technique Prolotherapy for Hypermobility Disorders of TMJ Using 25 % Dextrose: A Clinical Study, J Maxillofac Oral Surg 2017;16:226-230.
16. Zhou H, Xue Y, Liu P. Application of auriculotemporal nerve block and dextrose prolotherapy in exercise therapy of TMJ closed lock in adolescents and young adults, Head Face Med 2021;17:11.
17. Haggag MA, Al-Belasy FA, Said Ahmed WM. Dextrose prolotherapy for pain and dysfunction of the TMJ reducible disc displacement: A randomized, double-blind clinical study, J Craniomaxillofac Surg 2022;50:426-431.
18. Zarate MA, Frusso RD, Reeves KD et al. Dextrose Prolotherapy Versus Lidocaine Injection for Temporomandibular Dysfunction:A Pragmatic Randomized Controlled Trial, J Altern Complement Med 2020;26:1064-1073.
19. Mohammed MR, Hamad SA, Al-Dawoody AD et al. Effect of dextrose prolotherapy on internal derangement of the temporomandibular joint, Eur Rev Med Pharmacol Sci 2023;27:4883-4889.
20. Dasukil S, Shetty SK, Arora G, Degala S. Efficacy of Prolotherapy in Temporomandibular Joint Disorders: An Exploratory Study, J Maxillofac Oral Surg 2021;20:115-120.
21. Priyadarshini S, Gnanam A, Sasikala B et al. Evaluation of prolotherapy in comparison with occlusal splints in treating internal derangement of the temporomandibular joint - A randomized controlled trial, J Craniomaxillofac Surg 2021;49:24-28.
22. Zhou H, Hu K, Ding Y. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation, Br J Oral Maxillofac Surg 2014;52:63-66.
23. Mustafa R, Gungormus M, Mollaoglu N. Evaluation of the Efficacy of Different Concentrations of Dextrose Prolotherapy in Temporomandibular Joint Hypermobility Treatment, J Craniofac Surg 2018;29:e461-e465.
24. Refai H, Altahhan O, Elsharkawy R. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: a preliminary prospective, randomized, double-blind, placebo-controlled clinical trial, J Oral Maxillofac Surg 2011;69:2962-2970.
25. Oh S, Ettema AM, Zhao C et al. Dextrose-induced subsynovial connective tissue fibrosis in the rabbit carpal tunnel: A potential model to study carpal tunnel syndrome?, Hand (N Y)2008;3:34-40.
26. Cezairli B, Sivrikaya EC, Omezli MM et al. Results of Combined, Single-Session Arthrocentesis and Dextrose Prolotherapy for Symptomatic Temporomandibular Joint Syndrome: A Case Series, Journal of Alternative and Complementary Medicine 2017;23:771-777.
27. Hasanain F, Durham J, Moufti A et al. Adapting the diagnostic definitions of the RDC/TMD to routine clinical practice: a feasibility study, J Dent 2009;37:955-962.